{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:18:28Z","timestamp":1793927908144,"version":"4.8.0"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.3201\/eid3008.231596","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T03:08:40Z","timestamp":1722308920000},"source":"Crossref","is-referenced-by-count":25,"title":["Macrolide-Resistant <i>Mycoplasma pneumoniae<\/i> Infections among Children before and during COVID-19 Pandemic, Taiwan, 2017\u20132023"],"prefix":"10.3201","volume":"30","author":[{"given":"Tsung-Hua","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ping","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ching","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hsien","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiah-Sing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3008.231596-202407161615-R1","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1086\/319981","article-title":"Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.","volume":"32","author":"Principi","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3008.231596-202407161615-R2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","article-title":"Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.","volume":"16","author":"Morozumi","year":"2010","journal-title":"J Infect Chemother"},{"key":"key-10.3201\/eid3008.231596-202407161615-R3","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3389\/fmicb.2016.00974","article-title":"Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment.","volume":"7","author":"Pereyre","year":"2016","journal-title":"Front Microbiol"},{"key":"key-10.3201\/eid3008.231596-202407161615-R4","doi-asserted-by":"publisher","first-page":"2100746","DOI":"10.2807\/1560-7917.ES.2022.27.19.2100746","article-title":"Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.","volume":"27","author":"Meyer Sauteur","year":"2022","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid3008.231596-202407161615-R5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s10156-012-0523-3","article-title":"Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan.","volume":"19","author":"Wu","year":"2013","journal-title":"J Infect Chemother"},{"key":"key-10.3201\/eid3008.231596-202407161615-R6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jmii.2021.09.010","article-title":"The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019-2020.","volume":"55","author":"Kuo","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"key-10.3201\/eid3008.231596-202407161615-R7","doi-asserted-by":"publisher","first-page":"1169.e1","DOI":"10.1016\/j.cmi.2020.09.035","article-title":"Clonal spread of macrolide-resistant Mycoplasma pneumoniae sequence type-3 and type-17 with recombination on non-P1 adhesin among children in Taiwan.","volume":"27","author":"Hung","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid3008.231596-202407161615-R8","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1128\/JCM.01301-15","article-title":"Development of a multilocus sequence typing scheme for molecular typing of Mycoplasma pneumoniae.","volume":"53","author":"Brown","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid3008.231596-202407161615-R9","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.3201\/eid2609.191575","article-title":"Sequence type changes associated with decreasing macrolide-resistant Mycoplasma pneumoniae, Japan.","volume":"26","author":"Morozumi","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid3008.231596-202407161615-R10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jmii.2021.07.011","article-title":"Persistent high macrolide resistance rate and increase of macrolide-resistant ST14 strains among Mycoplasma pneumoniae in South Korea, 2019-2020.","volume":"55","author":"Lee","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"key-10.3201\/eid3008.231596-202407161615-R11","first-page":"511","article-title":"New laboratory techniques for isolation of Mycoplasma pneumoniae.","volume":"56","author":"Tully","year":"1983","journal-title":"Yale J Biol Med"},{"key":"key-10.3201\/eid3008.231596-202407161615-R12","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1128\/JCM.00321-07","article-title":"Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach.","volume":"45","author":"Dumke","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid3008.231596-202407161615-R13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jinf.2021.06.018","article-title":"Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19.","volume":"83","author":"Mendez-Brito","year":"2021","journal-title":"J Infect"},{"key":"key-10.3201\/eid3008.231596-202407161615-R14","doi-asserted-by":"publisher","first-page":"e2220949","DOI":"10.1001\/jamanetworkopen.2022.20949","article-title":"Global trends in the proportion of macrolide-resistant Mycoplasma pneumoniae infections: a systematic review and meta-analysis.","volume":"5","author":"Kim","year":"2022","journal-title":"JAMA Netw Open"},{"key":"key-10.3201\/eid3008.231596-202407161615-R15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13756-019-0576-5","article-title":"Antimicrobial susceptibility and molecular characteristics of Mycoplasma pneumoniae isolates across different regions of China.","volume":"8","author":"Zhao","year":"2019","journal-title":"Antimicrob Resist Infect Control"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/8\/23-1596_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T18:38:26Z","timestamp":1732905506000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/8\/23-1596_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3008.231596","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}